טוען...
Autoimmune complications of cancer immunotherapy
Immunotherapy of cancer with blockade of inhibitory immune checkpoints and adoptive cell therapies have led to impressive clinical responses in several cancers. However, with increasing utilization of these therapies, immune-related adverse events have emerged as a major obstacle. Herein I discuss r...
שמור ב:
| הוצא לאור ב: | Curr Opin Immunol |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968474/ https://ncbi.nlm.nih.gov/pubmed/31557690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2019.08.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|